Researchers have identified anti-CHRM autoantibodies in some people with Long COVID, particularly those with autonomic symptoms such as dizziness, palpitations and brain fog. This article explains what these antibodies are, why scientists are studying them, and whether they could one day lead to better diagnosis or targeted treatments.
